Jeremy S. Abramson, MD¹, Amy S. Ruppert, PhD^2,3, Sharmila Giri, MS^2,4*, Ann Hudson^2,4*, Eric D. Hsi, MD⁵, Richard F. Little, MD, MPH⁶, Steven D. Gore, MD⁶, Anusha Vallurupalli, MD^7*, Daniel J Landsburg, MD⁸, Brad S. Kahl, MD⁹, Jonathan W. Friedberg, MD¹⁰, Nancy L. Bartlett, MD⁹ and John P. Leonard, MD¹¹

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Alliance Statistics and Data Center, Rochester, MN
³Center for Biostatistics, The Ohio State University, Columbus, OH
⁴Mayo Clinic, Rochester, MN
⁵Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
⁶Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
⁷University of Kansas Cancer Center, Kansas City, KS
⁸Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹⁰Wilmot Cancer Institute, University of Rochester, Rochester, NY
¹¹Weill Cornell Medicine, New York, NY

Mark Roschewski, MD¹, James D. Phelan, PhD^2*, Stefania Pittaluga, MD, PhD³, Christopher Melani, MD⁴, Rahul Lakhotia, MBBS², Jacob J. Chabon, PhD^5*, Jagan R. Muppidi, MD, PhD^2*, Kathryn A. Lurain, MD, MPH^6,7, Jillian Simard, MD², Amynah Pradhan, CRNP-F^2*, Amy Hillsman, CRNP^2*, Madeline Rilko, RN^2*, Seth M. Steinberg, PhD^8*, George W. Wright, PhD^9*, Da Wei Huang, MD^2*, Yandan Yang, PhD^9*, Michail S. Lionakis, MD, ScD^10*, Alexander Bagaev, PhD^11*, Ekaterina Postovalova, PhD^11*, Mark Meerson, MS^12*, Olga Kudryashova, MS^12*, Nikita Kotlov, MS^12*, Nathan H. Fowler, MD¹², David M. Kurtz, MD, PhD¹³, Ash A. Alizadeh, MD, PhD¹⁴, Elaine S. Jaffe, MD³, Louis M. Staudt, MD, PhD² and Wyndham H. Wilson, MD, PhD²

¹Lymphoid Malignancies Branch, Center for Cancer Research, Lymphoid Malignancies Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Lymphoid Malignancies Branch, Center for Cancer Research, National Institutes of Health, Derwood, MD
⁵Foresight Diagnostics, Aurora, CO
⁶HIV/AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD
⁷National Cancer Institute, Bethesda, MD, USA, Bethesda, MD
⁸Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda
¹⁰Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
¹¹BostonGene Corp., Waltham, MA
¹²BostonGene, Corp, Waltham, MA
¹³Stanford University, Stanford, CA
¹⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

Martin Hutchings^1*, Anna Sureda², María José Terol, MD PhD^3*, Francesc Bosch Albareda^4*, Paolo Corradini, MD⁵, Thomas Stauffer Larsen^6*, Antonio Rueda Dominguez^7*, Anesh Panchal^8*, Alessia Bottos^9*, David Carlile^8*, Yanjie Wang^10*, Audrey Filézac De L'Étang^9*, Maneesh Tandon^8*, Gila Sellam^9* and Giuseppe Gritti^11*

¹Rigshospitalet, Copenhagen, Denmark
²Universitat de Barcelona, Barcelona, Spain
³Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
⁴University Hospital Vall d'Hebron, Barcelona, Spain
⁵University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁶Odense University Hospital, Odense, Denmark
⁷Regional and Virgen de la Victoria University Hospitals, Málaga, Spain
⁸Roche Products Ltd, Welwyn Garden City, United Kingdom
⁹F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁰F. Hoffmann-La Roche Ltd, Shanghai, China
¹¹Ospedale Papa Giovanni XXIII, Bergamo, Italy

Moshe Y. Levy, MD¹, Deepa Jagadeesh, MD², Zhanet Grudeva-Popova, MD^3*, Marek Trněný, MD⁴, Wojciech Jurczak, MD, PhD^5*, Halyna Pylypenko^6*, Marc André, MD^7*, Sunita Dwivedy Nasta, MD⁸, Dalit Rechavi-Robinson^9*, Sara Toffanin^9*, Sandrine Micallef^9*, Antoine Attinger^9*, Elisabeth Rouits^9*, Marie-Claude Roubaudi-Fraschini^9*, Panos Orfanos^9*, Mariola Dymkowska, MD^9*, Heidi Nauwelaerts^9* and Sherida Woei-a-Jin, MD MSc^10*

¹Baylor Charles A. Sammons Cancer Center, Dallas, TX
²Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Clinical Oncology, Medical University of Plovdiv, Plovdiv, BGR
⁴First Dept. of Medicine- Hematology, Charles University General Hospital and First Faculty of Medicine, Prague, Czech Republic
⁵Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁶Regional Treatment and Diagnostics Haematology Centre, Cherkassy Regional Council, Cherkassy, Ukraine
⁷Department of Hematology, CHU Dinant-Godinne, UCL Namur, Yvoir, Belgium, Yvoir, Belgium
⁸Lymphoma Program, University of Pennsylvania Medical Center, Philadelphia, PA
⁹Debiopharm International SA, Lausanne, Switzerland
¹⁰Department of Hematology, University Hospitals Leuven, Leuven, Belgium

John M. Burke, MD¹, Gustavo Fonseca, MD^2*, Wojciech Jurczak, MD, PhD^3*, Jason Melear, MD⁴, Miguel Islas-Ohlmayer, MD⁵, James A Reeves, MD^6*, Parameswaran Venugopal, MD⁷, Tomasz Wróbel, MD, PhD⁸, Don Stevens, MD⁹, John M. Pagel, MD, PhD¹⁰, Jerome Goldschmidt, MD^11*, Hari P. Miskin, MSc¹², Peter Sportelli, BS¹², Owen A. O'Connor, MD, PhD^12* and Nilanjan Ghosh, MD, PhD¹³

¹Rocky Mountain Cancer Centers / US Oncology Research, Aurora, CO
²Florida Cancer Specialists North/Sarah Cannon Research Institute, St. Petersburg, FL
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁴Texas Oncology, Austin, TX
⁵Oncology Hematology Care, Cincinnati, OH
⁶Florida Cancer Specialists South / Sarah Cannon Research Institute, Fort Myers, FL
⁷Rush University Medical Center, Chicago, IL
⁸Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
⁹Norton Cancer Institute, Louisville, KY
¹⁰Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
¹¹Blue Ridge Cancer Care / US Oncology Research, Blacksburg, VA
¹²TG Therapeutics, Inc., New York, NY
¹³Department of Hematology, Lymphoma Division, Assistant Professor of Medicine, Levine Cancer Institute/Atrium Health, Charlotte, NC

Michael Wang, MD¹, Matthew Mei, MD², Paul M. Barr, MD³, Jacqueline Barrientos, MD, MS⁴, Sven de Vos⁵, Richard Furman⁶, Krish Patel^7*, Philip A. Thompson¹, Michael Choi⁸, Avyakta Kallam, MD⁹, Ying Zhu^10*, Samhita Chakraborty^10*, Patricia Marinello^10* and Stephen E. Spurgeon¹¹

¹MD Anderson Cancer Center, Houston, TX
²City of Hope Cancer Center, Duarte, CA
³University of Rochester, Rochester, NY
⁴Northwell Health, Inc., New Hyde Park, NY
⁵UCLA Santa Monica Medical Center, Santa Monica, CA
⁶Weill Cornell Medical College, New York, NY
⁷Swedish Cancer Institute, Seattle, WA
⁸University of California San Diego, San Diego, CA
⁹University of Nebraska Medical Center, Omaha, NE
¹⁰Merck & Co., Inc., Kenilworth, NJ
¹¹Oregon Health and Science University, Portland, OR